We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $936M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
+12.81%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$660M
AUM Growth
+$27.9M
Cap. Flow
+$3.66M
Cap. Flow %
0.56%
Top 10 Hldgs %
67.45%
Holding
40
New
9
Increased
8
Reduced
8
Closed
6

Top Buys

Rank Stock Value
1
CMP icon
Compass Minerals
CMP
+$20.6M
2
QDEL icon
QuidelOrtho
QDEL
+$14.5M
3
MAGN
Magnera Corp
MAGN
+$13.4M
4
SITC icon
SITE Centers
SITC
+$13.2M
5
INDV icon
Indivior Pharmaceuticals
INDV
+$11.1M

Top Sells

Rank Stock Value
1
MRP
Millrose Properties Inc
MRP
+$31.5M
2
PPLI
People Inc
PPLI
+$26.6M
3
AMN icon
AMN Healthcare
AMN
+$19M
4
TSVT
2seventy bio
TSVT
+$12.5M
5
CLFD icon
Clearfield
CLFD
+$8.92M

Sector Composition

Rank Sector Weight
1 Healthcare 28.7%
2 Real Estate 17.14%
3 Consumer Discretionary 15.18%
4 Communication Services 11.81%
5 Industrials 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITOS
26
DELISTED
iTeos Therapeutics
ITOS
$5.66M 0.86%
+567,416
New +$4.57M
RCKT icon
27
Rocket Pharmaceuticals
RCKT
$355M
$4.9M 0.74%
+2,000,000
New +$10.1M
MITK icon
28
Mitek Systems
MITK
$768M
$4.8M 0.73%
484,954
-236,600
-33% -$2.12M
KROS icon
29
Keros Therapeutics
KROS
$202M
$3.3M 0.5%
+246,857
New +$3.33M
ABEO icon
30
Abeona Therapeutics
ABEO
$349M
$2.73M 0.41%
480,000
– –
WVE icon
31
Wave Life Sciences
WVE
$1.14B
$2.6M 0.39%
400,000
– –
AVIR icon
32
Atea Pharmaceuticals
AVIR
$386M
$2.09M 0.32%
580,000
– –
ETNB
33
DELISTED
89bio
ETNB
$1.96M 0.3%
200,000
– –
MURA
34
DELISTED
Mural Oncology
MURA
$1.41M 0.21%
570,000
– –
CLFD icon
35
Clearfield
CLFD
$436M
– –
-300,000
Closed -$8.92M
LKFT
36
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
– –
-200,000
Closed -$5.02M
THRD
37
DELISTED
Third Harmonic Bio
THRD
– –
-635,150
Closed -$2.2M
TSVT
38
DELISTED
2seventy bio
TSVT
– –
-2,534,836
Closed -$12.5M
VTOL icon
39
Bristow Group
VTOL
$1.37B
– –
-18,080
Closed -$571K
USAR
40
USA Rare Earth Inc
USAR
$3.65B
– –
-692,650
Closed -$7.62M
1
2

Similar funds

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PWAM
Private Wealth Asset Management Cedar Rapids, Iowa $935M AUM 17.66% 1-Year Est. Return
LJAC
L.J. Altfest & Co New York $935M AUM 27.19% 1-Year Est. Return
NI
NetEase Inc Hangzhou, China $934M AUM 11.31% 1-Year Est. Return
MCM
Massar Capital Management Stamford, Connecticut $934M AUM 14.18% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $934M AUM 26.74% 1-Year Est. Return
TW
TritonPoint Wealth Chevy Chase, Maryland $934M AUM 23.95% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Newtyn Management's Q2 2025 Portfolio in Review

As of Q2 2025, Newtyn Management held 40 positions worth $660M, up 4.4% from $632M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Newtyn Management's Q2 2025 filing shows 9 new, 8 increased, 8 reduced and 6 closed positions. Its largest new stake was Compass Minerals: 1,277,183 shares worth $25.7M. The largest sale was Millrose Properties Inc, an estimated $31.5M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 26% a quarter earlier, followed by Real Estate and Consumer Discretionary.

  • Newtyn Management's largest Q2 2025 buy was Compass Minerals: 1,277,183 shares worth $25.7M.
  • Newtyn Management added most to QuidelOrtho in Q2 2025, an estimated $14.5M increase.
  • Newtyn Management's biggest Q2 2025 reduction was Millrose Properties Inc, cutting an estimated $31.5M.
  • Newtyn Management fully exited 2seventy bio in Q2 2025, selling an estimated $12.5M.
  • Newtyn Management's ten largest holdings make up 67% of its $660M portfolio in Q2 2025.
  • Newtyn Management opened 9 new positions and closed 6 in Q2 2025.
  • Newtyn Management's portfolio value rose 4.4% quarter-over-quarter to $660M.

Based on Newtyn Management's 13F filing for Q2 2025, filed 14 Aug 2025.